Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone for recurrent implantation failure
ChiCTR1800018783Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Recurrent Implantation Failure (RIF) and infertility comparing Prednisone group with Placebo group (2 arms). Primary endpoint: live birth rate. Started Nov 2018; status: recruiting.
02
Drugs
prednisone
03
Conditions
Recurrent Implantation Failure (RIF)infertility
Beyond the preview
Go deeper on ChiCTR1800018783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018783.